Airsculpt Technologies, Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
AIRS$0.72-10.6%Stored close · as of Nov 12, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Checking your notes…
| Twelve Months EndedDecember 31, | |||
|---|---|---|---|
| ($000s) | 2025 | 2024 | 2023 |
| Cash flows from operating activities | |||
| Net loss | $(11,667) | $(8,018) | $(4,240) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Depreciation and amortization | 12,781 | 11,888 | 10,253 |
| Equity-based compensation | 2,331 | 3,762 | 18,224 |
| Non-cash interest expense; amortization of debt costs | 525 | 339 | 207 |
| Deferred income taxes | (5,914) | (252) | 1,342 |
| Loss on impairment of long-lived assets | 4,575 | 16 | (212) |
| Cost related to closing location | 2,152 | — | — |
| Changes in assets and liabilities | |||
| Taxes receivable | 1,556 | (1,115) | 890 |
| Prepaid expense and other current assets | (4,440) | (2,059) | 466 |
| Other assets | 6,669 | (2,882) | (4,711) |
| Accounts payable | 579 | 739 | (206) |
| Deferred revenue and patient deposits | 735 | (293) | (896) |
| Accrued and other liabilities | (6,786) | 9,225 | 2,839 |
| Net cash used in operating activities | 3,096 | 11,350 | 23,956 |
| Cash flows from investing activities | |||
| Purchases of property and equipment, net | (2,404) | (14,007) | (9,919) |
| Net cash used in investing activities | (2,404) | (14,007) | (9,919) |
| Cash flows from financing activities | |||
| Payments on term loan | (13,793) | (2,125) | (12,125) |
| Payments for debt modification | (393) | (136) | — |
| Payments on revolving credit facility | (5,000) | 5,000 | — |
| Proceeds from public offerings, net | 18,764 | — | — |
| Distribution to member | — | — | (79) |
| Dividends paid to shareholders | — | (252) | (385) |
| Payment of taxes withheld through vested equity-based compensation | (56) | (903) | (233) |
| Other financing activity | — | (954) | (569) |
| Net cash used in financing activities | (478) | 630 | (13,391) |
| Net decrease in cash and cash equivalents | 214 | (2,027) | 646 |
| Cash and cash equivalents | |||
| Beginning of period | 8,235 | 10,262 | 9,616 |
| End of period | $8,449 | $8,235 | $10,262 |
| Supplemental disclosure of cash flow information: | |||
| Cash paid for interest | $5,562 | $5,997 | $6,277 |
| Supplemental disclosure of non-cash investing information: | |||
| Property and equipment included in accounts payable and accrued expenses | $1,578 | $1,595 | $283 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.